- Ocean Biomedical (NASDAQ:OCEA) acquired a notice from Nasdaq stating that as a result of the corporate has not but filed its quarterly report on Form 10-Q, it isn’t in compliance with Nasdaq Listing Rule 5250(c)(1).
- The firm is delayed in submitting the Form 10-Q on account of beforehand disclosed developments with respect to submitting of its 10-K for the yr ended December 31, 2023.
- Source: Press Release
More on Ocean Biomedical, Inc.
Source: Seekingalpha